Release Summary

CHMP Issues Positive Opinion for ORENCIA in the Treatment of Highly Active and Progressive Disease in Adult Patients with Rheumatoid Arthritis not Previously Treated with Methotrexate in the EU

Bristol-Myers Squibb Company